The regulation of allergy and asthma
- 21 July 2006
- journal article
- review article
- Published by Wiley in Immunological Reviews
- Vol. 212 (1), 238-255
- https://doi.org/10.1111/j.0105-2896.2006.00413.x
Abstract
Allergic diseases and asthma are caused by exaggerated T-helper 2 (Th2)-biased immune responses in genetically susceptible individuals. Tolerance to allergens is a mechanism that normally prevents such responses, but the specific immunological events that mediate tolerance in this setting are poorly understood. A number of recent studies indicate that regulatory T cells (Tregs) play an important role in controlling such Th2-biased responses. Tregs involved in regulating allergy and asthma consist of a family of related types of T cells, including natural CD25+ Tregs as well as inducible forms of antigen-specific adaptive Tregs. Impaired expansion of natural and/or adaptive Tregs is hypothesized to lead to the development of allergy and asthma, and treatment to induce allergen-specific Tregs could provide curative therapies for these problems.Keywords
This publication has 100 references indexed in Scilit:
- Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American populationJournal of Allergy and Clinical Immunology, 2005
- Potential role of interleukin-10-secreting regulatory T cells in allergy and asthmaNature Reviews Immunology, 2005
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL‐4 and eotaxin productionEuropean Journal of Immunology, 2004
- Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individualsAnnals of Allergy, Asthma & Immunology, 2004
- The pattern of atopic sensitization is associated with the development of asthma in childhoodJournal of Allergy and Clinical Immunology, 2001
- Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host DiseaseThe Journal of Experimental Medicine, 1999
- Allergen Immunotherapy: Therapeutic Vaccines for Allergic DiseasesAnnals of Allergy, Asthma & Immunology, 1998
- Generation of Antigen-Specific Suppressor Cells during Allergy DesensitizationNew England Journal of Medicine, 1980